Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03715231 · ClinicalTrials.gov registry record · NA
NIDEK Gonioscope GS-1 for Glaucoma
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT03715231 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 24 participants.
The verdict
NCT03715231, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The Gonioscope GS-1 is an ophthalmic camera with gonioscopic prism that is intended to capture, display and store images of the anterior chamber angle and its peripheral part. This study evaluates the efficiency of Gonioscope GS-1 in glaucoma patients.With the captured images, the glaucoma diagnosis and post-operative observation are enabled.
Interventions
- OTHER NIDEK Gonioscope GS-1
- OTHER Standard Digital Gonioscopic Images
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2019-06-12 |
| Est. Completion | 2021-05-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03715231
The ClinicalTrials.gov registry entry for NCT03715231 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which NIDEK Gonioscope GS-1 is the first listed.
NCT03715231 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03715231 about?
NCT03715231 is a clinical study titled "NIDEK Gonioscope GS-1 for Glaucoma". The Gonioscope GS-1 is an ophthalmic camera with gonioscopic prism that is intended to capture, display and store images of the anterior chamber angle and its peripheral part. This study evaluates the efficiency of Gonioscope GS-1 in glaucoma patients.With the captured images, the glaucoma diagnosis...
What is the current status of trial NCT03715231?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2019-06-12. Estimated completion is 2021-05-26.
What interventions are being tested in trial NCT03715231?
The interventions under investigation include: NIDEK Gonioscope GS-1 (OTHER), Standard Digital Gonioscopic Images (OTHER).
Who is sponsoring clinical trial NCT03715231?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.